El interés en corto de Verb Tech da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Verb Tech. Los datos de interés en corto se actualizan cada dos semanas.

Verb Tech (NASDAQ:VERB) Bolsa, Informe de interés en corto

Verb Tech

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. Available in over 60 countries and in mobile and desktop versions, it includes verbLIVE an interactive livestream eCommerce, shoppable video and webinar, verbCRM a customer relationship management, verbTEAMS a self on-boarding version of verbCRM with built-in verbLIVE and salesforce synchronization for small businesses, verbLEARN a learning management system and among others.

Verb Technology Company, Inc. - Common Stock

Verb Technology Co Inc

Verb Technology Co Inc WT EXP

Verbio SE

Verbund AG

Robert A. Hocking, senior vice president and global head of product innovation at Cboe Global Markets, revealed that Zero Days to Expiration (Zero DTE) options now account for nearly 47% of SPX trading volume in 2024.
That&#8217;s a dramatic rise from just eight years ago. 
&#8220;Zero DTE accounted for roughly 5% of SPX option volumes in 2016,&#8221; Hocking explained at Benzinga&#8217;s latest virtual event, <a href="https://www.benzinga.com/events/managing-volatile-markets-with-0dte-options/">Managing Volatile Markets with 0DTE Options</a>, which was sponsored by Cboe. &#8220;This has jumped to 45% by the end of 2023, and it's crept up to around 47% in 2024,&#8221; he added. 
As a result, SPX's overall trading volume has doubled daily to approximately 3 million contracts, compared to 1.5 million in 2016.
<h3 class="wp-block-heading">Retail And Institutional Traders Fuel Growth</h3>
Both retail and institutional traders have driven the rapid expansion of Zero DTE options. Initially embraced by retail traders, institutional participation has increased, further boosting liquidity in the market. 
Hocking noted that Zero DTE options are now a major part of the trading landscape, with institutional players helping sustain their growth.
&#8220;What's fascinating is that Zero DTE now represents 1.4 million contracts daily—more than the total SPX daily average volume in 2016,&#8221; Hocking stated. &#8220;It's become a crucial tool for managing short-term trades and risk exposure, which is why it's seen such broad adoption.&#8221;
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="CBOE - 0DTE Options &#x7C; Rob Hocking &#x7C; Benzinga Virtual Events" width="500" height="281" src="https://www.youtube.com/embed/9xq-YR-f22w?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h3 class="wp-block-heading">Impact on Market Volatility</h3>
Despite the surge in Zero DTE trading, concerns about its potential effect on market volatility have not been realized. Hocking emphasized that Cboe&#8217;s data shows no evidence linking these options to increased market turbulence. &#8220;We&#8217;ve been closely monitoring the data, and there&#8217;s no sign that Zero DTE options are adding risk to the market,&#8221; he said.
Introducing Zero DTE options has provided traders with new ways to manage both the upside and downside of their portfolios, offering greater flexibility in their strategies.
<h3 class="wp-block-heading">Future of Zero DTE Options</h3>
As Zero DTE trading continues to flourish, Cboe is exploring further opportunities to meet the growing demand from institutional investors. Hocking suggested that more tools and data will likely emerge as the market for these options expands.
&#8220;Zero DTE is here to stay,&#8221; Hocking concluded. &#8220;Its growth reflects the shift in how retail and institutional traders approach the options market.&#8221;
Now Read:
<ul>
<li><a href="https://www.benzinga.com/top-stories/24/09/41072065/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet">Benzinga&#8217;s &#8216;Stock Whisper&#8217; Index: 5 Stocks Investors Secretly Monitor But Don&#8217;t Talk About Yet</a></li>
</ul>
Image: Shutterstock

Events

Exclusives

Interview

Zero DTE Options Fuel Record SPX Trading Volumes, With No Signs Of Slowing Down: Expert

Even though the Chinese stock market has been scrutinized extensively in the past couple of years, some investors have begun to realize that there is much more upside than apparent risk for Asia&#39;s powerhouse. China&#39;s technology sector has the lowest valuation in history compared to its American counterpart.
Measured through the KraneShares CSI China Internet ETF (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kweb#NYSE">KWEB</a>), names in this space now trade at steep discounts against peers like Alphabet Inc. and even Amazon.com Inc.. While discounted stocks might not look attractive to some investors based on their price action, others recognize the value to be had in them.
This is why stocks like Alibaba Group (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baba#NYSE">BABA</a>), Baidu Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bidu#NASDAQ">BIDU</a>), and the overall iShares MSCI China ETF (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mchi#NASDAQ">MCHI</a>) have delivered shareholders a significant rally this week, one of the best performances since the few months after the COVID-19 pandemic. Retail investors can also feel a bit safer because some of Wall Street&#39;s favorite investors have also given these companies a chance to make billions.
<h2>Chinese Government Interventions Improve the Risk-Reward Balance for Investors</h2>
Recently, the Federal Reserve (the Fed) in the United States decided to lower interest rates by half a percent, or 50 basis points. The Chinese economy has been criticized long enough for its slowdown and contractions, so the government has also decided to cut rates by the same amount.
The difference is that the Chinese ETF trades at only 47% of the high prices it made in early 2021, while the technology-focused NASDAQ 100 index trades at 96% of its 52-week high now. This means that the potential reward is much bigger in China than the pullback the U.S. technology space could make after these runs.
Stanley Druckenmiller decided to sell out of NVIDIA Co. after realizing the potential upside was no longer that attractive; it is no surprise to see his former mentor and boss George Soros initiate a&nbsp;$73.4 million position in Alibaba.
As lower rates start to spread through the Chinese economy, the consumer discretionary sector and rate-dependent technology companies will probably see the benefits first, so they have become the top choice for other mega investors as well.
<h2>Who&#39;s Buying Chinese Stocks Now and What They&#39;re Adding to Their Portfolios</h2>
Some investors would recognize him for predicting the 2008 financial crisis, but Michael Burry has now made Alibaba his top holding. After buying it for the better part of 2024, Burry&#39;s portfolio is now reported to hold up to 155,000 shares valued at roughly $14.8 million today.
The trend doesn&#39;t end there for Burry, as he also chose Baidu as his fourth-largest position, with 75,000 shares valued at approximately $9 million. Coming right after Baidu, Burry chose JD.com Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) to be his fifth-largest position, with 250,000 shares carrying a value of $8.3 million today.
Those names are the common choice among investors today. David Tepper has recently deviated from his typical picks in the financial and technology sector to pick on Chinese stocks. For Tepper, his fund bought up to 10,500,000 shares for an approximate value of just over $1 billion in the portfolio.
Considering that Alibaba trades at less than a third of the $316 a share high it made after COVID-19, it makes sense for these investors to look at the potential risk-to-reward ratios and decide if it is worth taking a risk on Chinese stocks.
<h2>Wall Street&#39;s Latest Take on Alibaba and Baidu: Key Insights for Investors</h2>
Starting with Alibaba, analysts now justify a consensus price target of $107.6 a share on the stock, calling for 12.7% upside from where it trades today. However, those at Susquehanna decided to go above and beyond the consensus and place a $130 valuation on Alibaba, implying it could run by a much bigger 35.4% from today&#39;s price.
When it comes to Baidu, the stock trades at only 68% of its 52-week high to offer enough potential upside to consider it. This is why analysts at Citigroup see a potential case for the stock to trade as high as $155 a share, daring the stock to stage a massive 64.8% rally from where it has traded down to today.
Here are other insights for investors to consider: Alibaba&#39;s main competitor could be assumed to be Amazon, which is why the Chinese giant&#39;s 25.1x P/E ratio means a significant discount to Amazon&#39;s 46.0x valuation today. For Baidu, competition can only arguably be found in shares of Google.
Baidu&#39;s 12.4x P/E valuation would also offer investors a steep discount compared to Google&#39;s valuation of 23.3x P/E today, despite a recent selloff in that stock. When it comes to upside and diminished risk, investors all over are finding Chinese stocks to be the winners; maybe retail investors should, too.
The article &quot;<a href="https://www.marketbeat.com/stock-ideas/chinese-tech-stocks-rally-whats-behind-it-and-next-steps/">China&#39;s Tech Stocks Surge: What Top Investors Know That You Don&#39;t</a>&quot; first appeared on MarketBeat.

Asia

Government

Large Cap

News

Sector ETFs

Price Target

Federal Reserve

Markets

Analyst Ratings

Tech

Trading Ideas

ETFs

BABA

BIDU

KWEB

MCHI

China's Tech Stocks Surge: What Top Investors Know That You Don't

Financial giants have made a conspicuous bullish move on Home Depot. Our analysis of options history for Home Depot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HD#NYSE">HD</a>) revealed 17 unusual trades.
Delving into the details, we found 47% of traders were bullish, while 23% showed bearish tendencies. Out of all the trades we spotted, 10 were puts, with a value of $1,485,855, and 7 were calls, valued at $844,034.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $240.0 to $420.0 for Home Depot over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Home Depot's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Home Depot's whale activity within a strike price range from $240.0 to $420.0 in the last 30 days. 
<h3>Home Depot 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727464652_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$38.35</td>
<td>$36.45</td>
<td>$36.45</td>
<td>$400.00</td>
<td>$911.2K</td>
<td>49</td>
<td style="text-align: right;">250</td>
</tr>
<tr>
<td>HD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>10/18/24</td>
<td>$23.5</td>
<td>$21.5</td>
<td>$23.5</td>
<td>$380.00</td>
<td>$453.5K</td>
<td>814</td>
<td style="text-align: right;">13</td>
</tr>
<tr>
<td>HD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$170.0</td>
<td>$165.0</td>
<td>$167.5</td>
<td>$240.00</td>
<td>$167.5K</td>
<td>124</td>
<td style="text-align: right;">10</td>
</tr>
<tr>
<td>HD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>10/25/24</td>
<td>$8.85</td>
<td>$7.35</td>
<td>$8.12</td>
<td>$400.00</td>
<td>$97.4K</td>
<td>1.0K</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>HD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$6.7</td>
<td>$6.3</td>
<td>$6.3</td>
<td>$355.00</td>
<td>$94.5K</td>
<td>62</td>
<td style="text-align: right;">150</td>
</tr>
</tbody>
</table>

<h3>About Home Depot</h3>
Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the US, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of Interline Brands in 2015 allowed Home Depot to enter the MRO business, which has been expanded through the tie-up with HD Supply (2020). The additions of the Company Store brought textiles to the lineup, and Redi Carpet added multifamily flooring, while the recent tie-up with SRS will help grow professional demand.
Following our analysis of the options activities associated with Home Depot, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Home Depot</h3>
<ul>
<li>Currently trading with a volume of 1,357,020, the HD's price is up by 0.8%, now at $399.86. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 46 days.</li>
</ul>
<h3>Expert Opinions on Home Depot</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $394.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Melius Research lowers its rating to Buy with a new price target of $420. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Market Perform rating for Home Depot, targeting a price of $360. 
&#x2A; An analyst from Loop Capital has decided to maintain their Hold rating on Home Depot, which currently sits at a price target of $360. 
&#x2A; An analyst from DA Davidson persists with their Buy rating on Home Depot, maintaining a target price of $430. 
&#x2A; Consistent in their evaluation, an analyst from Oppenheimer keeps a Perform rating on Home Depot with a target price of $400. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Home Depot with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Home Depot's Options: A Look at What the Big Money is Thinking

Deep-pocketed investors have adopted a bearish approach towards ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in COP usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 14 extraordinary options activities for ConocoPhillips. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 35% leaning bullish and 57% bearish. Among these notable options, 4 are puts, totaling $169,201, and 10 are calls, amounting to $950,940.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $90.0 to $115.0 for ConocoPhillips over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for ConocoPhillips's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across ConocoPhillips's significant trades, within a strike price range of $90.0 to $115.0, over the past month.
<h3>ConocoPhillips 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727464647_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>10/04/24</td>
<td>$6.65</td>
<td>$6.6</td>
<td>$6.65</td>
<td>$97.00</td>
<td>$232.7K</td>
<td style="text-align: right;">350</td>
<td style="text-align: right;">350</td>
</tr>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/01/24</td>
<td>$2.71</td>
<td>$2.51</td>
<td>$2.63</td>
<td>$106.00</td>
<td>$191.7K</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">729</td>
</tr>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$7.85</td>
<td>$7.8</td>
<td>$7.8</td>
<td>$100.00</td>
<td>$158.3K</td>
<td style="text-align: right;">64</td>
<td style="text-align: right;">308</td>
</tr>
<tr>
<td>COP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$7.85</td>
<td>$7.8</td>
<td>$7.8</td>
<td>$100.00</td>
<td>$74.8K</td>
<td style="text-align: right;">64</td>
<td style="text-align: right;">498</td>
</tr>
<tr>
<td>COP</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$5.25</td>
<td>$5.05</td>
<td>$5.05</td>
<td>$100.00</td>
<td>$65.6K</td>
<td style="text-align: right;">226</td>
<td style="text-align: right;">243</td>
</tr>
</tbody>
</table>

<h3>About ConocoPhillips</h3>
ConocoPhillips is a US-based independent exploration and production firm. In 2023, it produced 1.2 million barrels per day of oil and natural gas liquids and 3.1 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2023 were 6.8 billion barrels of oil equivalent.
Following our analysis of the options activities associated with ConocoPhillips, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of ConocoPhillips</h3>
<ul>
<li>Currently trading with a volume of 3,140,217, the COP's price is up by 1.96%, now at $104.32. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 34 days.</li>
</ul>
<h3>Expert Opinions on ConocoPhillips</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $137.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Buy rating on ConocoPhillips, which currently sits at a price target of $140. 
&#x2A; An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $140. 
&#x2A; An analyst from Wells Fargo persists with their Overweight rating on ConocoPhillips, maintaining a target price of $132. 
&#x2A; An analyst from Mizuho has decided to maintain their Neutral rating on ConocoPhillips, which currently sits at a price target of $129. 
&#x2A; An analyst from Susquehanna persists with their Positive rating on ConocoPhillips, maintaining a target price of $147. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ConocoPhillips options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Spotlight on ConocoPhillips: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Charter Communications.
Looking at options history for Charter Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHTR#NASDAQ">CHTR</a>) we detected 17 trades.
If we consider the specifics of each trade, it is accurate to state that 64% of the investors opened trades with bullish expectations and 17% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $186,140 and 12, calls, for a total amount of $1,170,868.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $220.0 and $440.0 for Charter Communications, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Charter Communications's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Charter Communications's significant trades, within a strike price range of $220.0 to $440.0, over the past month.
<h3>Charter Communications Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727464642_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th style="text-align: right;">Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CHTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$102.0</td>
<td>$99.0</td>
<td>$100.5</td>
<td>$300.00</td>
<td>$376.2K</td>
<td style="text-align: right;">561</td>
<td style="text-align: right;">85</td>
</tr>
<tr>
<td>CHTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$104.6</td>
<td>$99.0</td>
<td>$102.0</td>
<td>$300.00</td>
<td>$234.6K</td>
<td style="text-align: right;">561</td>
<td style="text-align: right;">33</td>
</tr>
<tr>
<td>CHTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$104.3</td>
<td>$99.0</td>
<td>$102.0</td>
<td>$300.00</td>
<td>$153.0K</td>
<td style="text-align: right;">561</td>
<td style="text-align: right;">48</td>
</tr>
<tr>
<td>CHTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$91.9</td>
<td>$89.7</td>
<td>$91.9</td>
<td>$260.00</td>
<td>$64.3K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">7</td>
</tr>
<tr>
<td>CHTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>09/19/25</td>
<td>$130.4</td>
<td>$126.0</td>
<td>$127.9</td>
<td>$220.00</td>
<td>$63.9K</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
</tr>
</tbody>
</table>

<h3>About Charter Communications</h3>
Charter is the product of the 2016 merger of three cable companies, each with a decades-long history in the business: Legacy Charter, Time Warner Cable, and Bright House Networks. The firm now holds networks capable of providing television, internet access, and phone services to roughly 58 million US homes and businesses, around 40% of the country. Across this footprint, Charter serves 30 million residential and 2 million commercial customer accounts under the Spectrum brand, making it the second-largest US cable company behind Comcast. The firm also owns, in whole or in part, sports and news networks, including Spectrum SportsNet (long-term local rights to Los Angeles Lakers games), SportsNet LA (Los Angeles Dodgers), SportsNet New York (New York Mets), and Spectrum News NY1.
In light of the recent options history for Charter Communications, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Where Is Charter Communications Standing Right Now?</h3>
<ul>
<li>With a volume of 835,046, the price of CHTR is up 3.32% at $327.55. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 28 days.</li>
</ul>
<h3>What Analysts Are Saying About Charter Communications</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $347.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from RBC Capital downgraded its rating to Sector Perform, setting a price target of $345. 
&#x2A; An analyst from Citigroup has elevated its stance to Neutral, setting a new price target at $350. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Charter Communications options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

CHTR

Behind the Scenes of Charter Communications's Latest Options Trends

Cryptocurrency markets are finishing the week on a high, with Bitcoin peaking past $66,000 in midday trading.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$65,934</td>
<td>&nbsp;+1.1%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,705</td>
<td>&nbsp;+1.9%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$158.59</td>
<td>&nbsp;+1.3%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.1246</td>
<td>&nbsp;+5.3%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00002052</td>
<td>&nbsp;+10.9%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics: 
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 3.7% and daily active addresses rising by 1.3% for Bitcoin.</li>
<li>According to Coinglass data, 63,487 traders liquidated in the past 24 hours for $139.18 million, with $85 million being short liquidations.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41067814/bitcoin-pushes-above-65k-but-what-does-technical-analysis-say">Bitcoin Pushes Above $65K But What Does Technical Analysis Say?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41070034/bitcoin-smashes-through-66-000-as-etfs-take-in-365m-to-extend-their-inflow-streak-to-6-str">Bitcoin Smashes Through $66,000 As ETFs Take In $365M To Extend Their Inflow Streak To 6 Straight Days</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41070497/bitcoin-could-sail-to-70k-on-the-tailwinds-of-stablecoin-minting-chinese-stimulus-renewed-">Bitcoin Could Sail To $70K On The Tailwinds Of Stablecoin Minting, Chinese Stimulus, Renewed Altcoin Activity: 10x Research</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41072097/viral-baby-hippo-moo-deng-steals-spotlight-from-dogecoin-shiba-inu-this-trader-made-392-00">Viral Baby Hippo Moo Deng Steals Spotlight From Dogecoin, Shiba Inu: This Trader Made $392,000 With Over 1,000X Meme Coin Return</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Notcoin (CRYPTO: NOT)</td>
<td>&nbsp;$0.01048</td>
<td>&nbsp;&nbsp;+21.9%</td>
</tr>
<tr>
<td>Bonk (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BONK</a>)</td>
<td>&nbsp;$0.00002302</td>
<td>&nbsp;+12.2%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>&nbsp;$0.00001062</td>
<td>&nbsp;+12.1%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Analyst Benjamin Cowen <a href="https://x.com/intocryptoverse/status/1839704950059766012">sees</a> ETH moving up to its bull market support band, which would constitute a move to the $2,900s. 
Altcoin Psycho feels emboldened by the recent uptrend, <a href="https://x.com/AltcoinPsycho/status/1839692748363895218">saying</a> it is time to &#8220;play offense.&#8221; he has bought several undisclosed altcoins and will &#8220;check back&#8221; in 4 to 8 weeks.
Trader Tyrogue <a href="https://x.com/TyrogueD/status/1762876624826249595">implies</a> that retail investors will soon get interested in meme coins again due to the unit bias. He thinks they will wonder &#8220;what if this coin went to $1?&#8221; and buy accordingly.
Smileycapital thinks several fundamental factors are aligning for crypto to go higher:
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#8211; Seasonally &amp; cyclically most bullish quarters + year ahead &#8211; Risk beta has significant catch up room to major stocks &#8211; USA entered easing cycle &#8211; USA elections &#8211; China stimulating economy &#8211; Japan plans on doing the same^ &#8211; Gen Y &amp; Gen-Z desperate to hypergamble their way out <a href="https://t.co/2w089oRAAJ">pic.twitter.com/2w089oRAAJ</a>
&mdash; &#x1f642; (@smileycapital) <a href="https://twitter.com/smileycapital/status/1839686338339045845?ref_src=twsrc%5Etfw">September 27, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
 Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/41066762/if-you-invested-1000-in-bitcoin-dogecoin-and-shiba-inu-exactly-a-year-ago-this-crypto-woul">If You Invested $1000 In Bitcoin, Dogecoin, And Shiba Inu Exactly A Year Ago, This Crypto Would Give You The Best Returns Today</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BONK

$BTC

$DOGE

$ETH

$PEPE

$SHIB

$SOL

Bitcoin, Ethereum, Dogecoin Close Out Strong Week On A High: 'Play Offense,' Says Bullish Trader

Macro Notification

General

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Israeli Military Says In The Past Hour Fighter Jets Have Attacked Hezbollah Targets In Lebanon Including Weapons Launchers And Weapons Storage

Senior Israeli Official Says Israel Hopes Not To Have To Proceed With Ground Invasion In Lebanon, But Will Not Rule It Out

UBS analyst Kevin Mcveigh maintains Accenture (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) with a Buy and raises the price target from $400 to $415.

UBS Maintains Buy on Accenture, Raises Price Target to $415

Fission Uranium (OTC: <a class="ticker" href="https://www.benzinga.com/stock/fcuuf#OTC">FCUUF</a>) has completed the hearing before the Supreme Court of British Columbia regarding the approval of the final order for its acquisition by Paladin Energy Limited. The hearing began before the Court on Sept. 13, 2024, and ended on Sept. 26. Its decision on the final order is expected in the coming weeks.
Fission&#39;s acquisition by Paladin Energy, however, remains opposed by CGN Mining Company Limited (&quot;CGN&quot;), which holds an 11.26% stake in Fission. CGN is a subsidiary of China General Nuclear Power Corp.
Fission&#39;s shareholders voted in favor of the acquisition at the special meeting held on Sept. 9, 2024. The closure of the acquisition currently remains subject to receipt of the final order and clearance under the Investment Canada Act, as well as other customary conditions.
<h2>Fission Uranium-Paladin Energy Merger Overview</h2>
Fission Uranium inked the deal with the Australian miner, Paladin Energy , in June 2024. Per the agreement, Paladin Energy would acquire FCUUF&#39;s outstanding shares for an implied total equity value of C$1.14 billion ($0.846 billion).
The acquisition, if successful, will create a company with a pro forma market capitalization of $3.5 billion. It will be placed among the largest pure-play global uranium companies with a combined mineral resource of 544 million pounds of uranium and ore reserves of 157 million. It will have a solid portfolio of exploration, development and production assets, and a substantially increased international capital markets exposure.
Fission Uranium&#39;s shareholders will receive 0.1076 fully paid shares of Paladin Energy for each share held in FCUUF. On completion, existing Paladin Energy and Fission Uranium shareholders will own around 76% and 24% of the combined entity, respectively.
Paladin Energy has applied for the listing of its shares on the Toronto Stock Exchange concurrent with the completion of the transaction. Consequently, Fission Uranium shareholders will receive TSX-listed Paladin Energy shares.
<h2>FCUUF Buyout to Strengthen Paladin Energy&#39;s Uranium Portfolio</h2>
Paladin Energy is an independent uranium producer with 75% ownership of the world-class long-life Langer Heinrich Mine located in Namibia. It also owns a portfolio of uranium exploration and development assets in Canada and Australia.&nbsp; Through its Langer Heinrich Mine, it delivers uranium to major nuclear utilities across the world. It has a 17-year estimated mine life and a nameplate annual capacity of 6 million pounds of uranium.
The acquisition of Fission Uranium will make Paladin Energy the 100% owner of the Patterson Lake South uranium property. It is a proposed high-grade uranium mine and mill in Canada&#39;s Athabasca Basin region. The feasibility study for the property projects a 10-year mine life with an annual production of 9.1 million pounds of uranium.
This move will help Paladin Energy capitalize on the growing demand for uranium. Several factors are driving this demand, such as the need for more electricity generation and the global push to decarbonize electrical grids, among others.
Over the past few years, the global uranium market has undergone a shift from an inventory-driven to a production-driven market.&nbsp; Underinvestment in uranium mining operations over the past decade has been the reason for a structural deficit between global production and uranium requirements.&nbsp; In 2024 and 2025, the gap between production and demand is projected to be more than 66 million pounds of uranium. This gap is expected to reach more than 400 million pounds by 2034. Uranium prices will be supported by robust demand and tight supply.
<h2>Fission Uranium Stock&#39;s Price Performance</h2>
Shares of Fission Uranium have gained 11.1% in the past year compared with the industry&#39;s 37.7% growth.
<img alt="Zacks Investment Research" src="https://staticx-tuner.zacks.com/images/articles/charts/8a/79511.jpg?v=1484847009" />
Image Source: Zacks Investment Research
<h2>FCCUF&#39;s Zacks Rank &amp; Stocks to Consider</h2>
Fission Uranium currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the basic materials space are Carpenter Technology Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/crs#NYSE">CRS</a>), Eldorado Gold Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ego#NYSE">EGO</a>) and IAMGOLD Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iag#NYSE">IAG</a>). Each of these stocks sports a Zacks Rank #1 (Strong Buy) at present.
The Zacks Consensus Estimate for Carpenter Technology&#39;s fiscal 2025 earnings is pegged at $6.06 per share. The consensus estimate for earnings has moved 17% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 15.9%. CRS&#39; shares have gained 129% in a year.
The consensus estimate for Eldorado Gold&#39;s 2024 earnings is pegged at $1.32 per share. The consensus estimate for earnings has moved 16% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 430%. EGO&#39;s shares have gained 106% in a year.
The Zacks Consensus Estimate for IAMGOLD&#39;s 2024 earnings is pegged at 39 cents per share. The consensus estimate for earnings has moved 44% north in the past 60 days. It has an average trailing four-quarter earnings surprise of 200%. IAG&#39;s shares have gained 160% in a year.
<a href="https://www.zacks.com/stock/news/2342763/fission-uranium-awaits-court-decision-on-acquisition-by-paladin-energy?cid=CS-BENZ-FT-analyst_blog|company_news_corporate_actions-2342763">To read this article on Zacks.com click here.</a>

Earnings

Mid Cap

Penny Stocks

Small Cap

Legal

FCUUF

Fission Uranium Awaits Court Decision on Acquisition by Paladin Energy

Senior Israeli Official Says Israel Is The Only Force Actively Fighting Iran And Its Proxies; Says That He Can't Say What Will Evolve, But That This Could Be A Pivot; Israel Doesn't Seek A Broader War; Says It's Too Early To Say If Israeli Strike Hit Nasrallah

The refinancing of debt and a raised credit rating by S&amp;P Global has AMC Entertainment Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) CEO Adam Aron increasingly optimistic than ever about the long-term outlook of the <a href="https://www.benzinga.com/topic/movie-theater-stocks">movie theater stock</a>.
What Happened: While speaking at the Variety Entertainment and Technology Summit Thursday, Aron shared the impact of the <a href="https://www.benzinga.com/general/entertainment/24/07/39915020/are-the-good-times-about-to-roll-at-amc-adam-aron-highlights-staggering-box-office-lineup-g">strong summer box office </a>and refinancing as key catalysts for the company.
"I'm a relieved human being," Aron <a href="https://variety.com/2024/film/news/amc-theatres-adam-aron-optimistic-upgrades-1236157370/">said </a>of the refinancing. "In July, we were able to announce that we'd worked agreements with 150 different lending institutions that will refinance most of our long-term debt and push our maturities."
Perhaps the &#8220;most important thing&#8221; AMC did was negotiate with lenders to refinance its debt again in 2026, &#8220;pushing it out further than 2030," Aron added.
The AMC CEO also referenced IMAX CEO Rich Gelfound in his keynote, saying the executive is "sure that Harry Houdini works at AMC," due to the company's magic-like ability to survive against the odds.
Read Also: <a href="https://www.benzinga.com/general/entertainment/24/05/39010959/amc-ceo-says-were-still-here-how-taylor-swift-popcorn-buckets-help-movie-theater-from-going">AMC CEO Says &#8216;We&#8217;re Still Here&#8217;: How Taylor Swift, Popcorn Buckets Help Movie Theater From Going &#8216;Kaplooey&#8217;</a>
Along with refinancing debt, Aron shared the impact that several strong box office blockbusters could have on future financials.
Box office earnings from June to September were more than double the previous five months. They went from $1.5 billion to $3.5 billion, Aron added.
Among the movies that helped were "Inside Out 2," "Despicable Me 4" and "Deadpool &amp; Wolverine."
"I can tell you with such confidence that the combination of resolving our balance sheet with a rising box office means rising profitability," Aron said.
Aron said the movie industry has been playing defense in recent years. It has had to fight off the COVID-19 pandemic impact plus Hollywood labor strikes.
"We get to play on offense again."
Price Action: AMC stock is up 1% to $4.58 on Friday versus a 52-week trading range of $2.38 to $11.88. AMC stock is down 25% year-to-date, as seen on the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092724&amp;t=be2bearmibe3na1"> Benzinga Pro chart</a> below. The stock has fallen over 90% in the last five years.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent092724&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="999" height="495" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27142256/Screenshot-195.png" alt="" class="wp-image-570501" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27142256/Screenshot-195.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27142256/Screenshot-195-300x149.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/27142256/Screenshot-195-768x381.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/07/40080474/after-taylor-swift-and-beyonc-now-usher-goes-to-amc-will-shareholders-say-yeah-or-be-caught">Taylor Swift And Beyoncé, Now Usher Go To AMC: Will Shareholders Say &#8216;Yeah&#8217; Or Be &#8216;Caught Up&#8217; In Stock Drop?</a></li>
</ul>
Image: Shutterstock

Entertainment

AMC Survival Against Challenging Sector Brings Magic Comparison: 'Harry Houdini Works At AMC'

U.S. State Department Approves Possible Sale Of Advanced Anti-Radiation Guided Missiles-Extended Range And Related Equipment To Australia For An Estimated Cost Of $405M

On Thursday, the FDA approved&nbsp;Bristol Myers Squibb&nbsp;&amp; Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>)&nbsp;Cobenfy (xanomeline and trospium chloride, KarXT), an oral medication for&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/09/41064867/schizophrenia-treatment-revolution-fda-approves-bristol-myers-squibb-cobenfy-as-new-class-of-trea" rel="noreferrer noopener">schizophrenia in adults</a>.
BMO Capital analyst notes that the FDA approval without a boxed warning is a significant positive for Bristol Myers shares.
The analyst notes that given that many prior antipsychotic medications received black box warnings due to increased mortality risks, particularly in elderly patients, Cobenfy&#8217;s absence of such a warning could significantly enhance its potential in treating Alzheimer&#8217;s related-psychosis, pending further clinical trials.
BMO projects peak sales of $2.4 billion for Cobenfy in schizophrenia and $3.9 billion in Alzheimer&#8217;s related-psychosis, raising the price target to $53 from $48, with a <a target="_blank" href="https://www.benzinga.com/quote/BMY/analyst-ratings" rel="noreferrer noopener">Market Perform rating</a>.
The analyst notes that Cobenfy will be priced at $1,850 for a 30-day supply or $22,500/year, representing a discount to previous expectations.
Truist Securities highlights that AbbVie Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) is also advancing emraclidine as a treatment for schizophrenia and Alzheimer&#8217;s disease-related psychosis.
According to Truist analysts, emraclidine differs from KarXT in its mechanism of action.
Despite emerging competition, Truist points out that KarXT holds a first-mover advantage and is ahead by at least two to three years.
Truist maintains the Buy rating and a price target of $62.
William Blair projects peak U.S. sales for Cobenfy to reach approximately $2 billion by 2030, driven solely by its use in treating schizophrenia.
However, if the drug is approved for additional indications, such as Alzheimer-related psychosis and adjunctive schizophrenia—both currently in Phase 3 trials—annual sales could rise to around $3 billion to $5 billion, pending positive results.
The analyst points out that although the label lacks a black box warning, it does include caution for urinary retention, elevated heart rate, reduced gastric motility, and angioedema.
Price Action: BMY stock is up 2.33% at $51.29&nbsp;at the last check on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/09/41070911/fda-removes-clinical-hold-on-biomea-fusions-early-stage-trials-for-potential-diabetes-candidate" target="_blank" rel="noreferrer noopener">FDA Removes Clinical Hold On Biomea Fusion&#8217;s Early-Stage Trials For Potential Diabetes Candidate</a>.</li>
</ul>

Analyst Color

Biotech

Health Care

Movers

ABBV

Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential

<a href="https://www.youtube.com/watch?v=RXIt6NuJqn0" title="https://www.youtube.com/watch?v=RXIt6NuJqn0">https://www.youtube.com/watch?v=RXIt6NuJqn0</a>

Politics

LIVE: Trump delivers remarks on inflation and economy at Michigan rally - Fox News

Asset Sales

AUMN

Golden Minerals Signs Definitive Agreement To Sell El Quevar Silver Project To Butte Energy For $3.5M, With Closing Expected By October 31, 2024

Investors with a lot of money to spend have taken a bearish stance on Microchip Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCHP#NASDAQ">MCHP</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MCHP, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 8 uncommon options trades for Microchip Technology.
This isn't normal.
The overall sentiment of these big-money traders is split between 25% bullish and 75%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $159,517, and 4 are calls, for a total amount of $276,980.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $67.5 to $92.5 for Microchip Technology over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Microchip Technology stands at 3441.71, with a total volume reaching 2,314.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Microchip Technology, situated within the strike price corridor from $67.5 to $92.5, throughout the last 30 days.
<h3>Microchip Technology Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1727463806_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th style="text-align: right;">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MCHP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$1.55</td>
<td>$1.4</td>
<td>$1.5</td>
<td>$92.50</td>
<td>$120.6K</td>
<td>7.1K</td>
<td style="text-align: right;">905</td>
</tr>
<tr>
<td>MCHP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/15/24</td>
<td>$3.6</td>
<td>$3.2</td>
<td>$3.5</td>
<td>$85.00</td>
<td>$65.8K</td>
<td>1.7K</td>
<td style="text-align: right;">188</td>
</tr>
<tr>
<td>MCHP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$3.4</td>
<td>$3.1</td>
<td>$3.4</td>
<td>$67.50</td>
<td>$59.5K</td>
<td>35</td>
<td style="text-align: right;">175</td>
</tr>
<tr>
<td>MCHP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$10.6</td>
<td>$10.4</td>
<td>$10.6</td>
<td>$75.00</td>
<td>$45.5K</td>
<td>418</td>
<td style="text-align: right;">45</td>
</tr>
<tr>
<td>MCHP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/18/24</td>
<td>$0.75</td>
<td>$0.6</td>
<td>$0.6</td>
<td>$90.00</td>
<td>$45.0K</td>
<td>10.5K</td>
<td style="text-align: right;">784</td>
</tr>
</tbody>
</table>

<h3>About Microchip Technology</h3>
Microchip Technology became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
<h3>Where Is Microchip Technology Standing Right Now?</h3>
<ul>
<li>With a volume of 2,959,783, the price of MCHP is up 0.89% at $81.02. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 34 days.</li>
</ul>
<h3>What Analysts Are Saying About Microchip Technology</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $80.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Truist Securities has revised its rating downward to Hold, adjusting the price target to $80. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Microchip Technology with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

MCHP

What the Options Market Tells Us About Microchip Technology

RBC Capital Markets analyst Ashish Sabadra initiated coverage on Intercontinental Exchange Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) at an Outperform rating and <a target="_blank" href="https://www.benzinga.com/quote/ICE/analyst-ratings" rel="noreferrer noopener">a price target of $200</a>.
The analyst writes that Mortgage technology is poised for double-digit growth, driven by synergies from the BKI acquisition and a recovering market.
The analyst adds that ICE Bonds are expected to benefit from digitization, while ICE Indices will gain from the shift to passive fixed-income investing.
Sabadra says that the business model is recession-resilient, capitalizing on increased volatility and strong franchises in mortgage origination and servicing, energy benchmarks, the NYSE, and fixed-income indices.
The analyst says that ICE should see mid-single to high-single-digit (MSD-HSD) revenue growth from this sector, supported by strong sales momentum and an expanding implementation pipeline. In addition, opportunities to upsell and cross-sell to the fixed income customer base are anticipated.
In the energy sector, ICE is projected to sustain solid double-digit revenue growth. Increased volatility from macroeconomic, geopolitical, and regulatory uncertainties is expected to drive higher demand for hedging. The shift towards passive fixed income investing should similarly benefit ICE Indices, with the strong franchise likely to support accelerated growth.
Regarding cost synergies and operating leverage, ICE forecasts approximately $200 million from BKI cost synergies by the fifth year post-acquisition. This, coupled with ongoing deleveraging and dividends yielding over 1%, is predicted to generate low teens-plus Total Shareholder Return (TSR) annually.
On a strategic level, ICE plans to use its substantial Free Cash Flow (FCF) primarily for debt reduction in the coming quarters, aiming to lower its leverage ratio to around 3.0x. This is part of a broader strategy to optimize its balance sheet while maintaining the capacity for shareholder returns and strategic acquisitions.
ICE&#8217;s diverse revenue streams, strategic positioning within key financial markets, and technological capabilities in mortgage and data services underpin its robust competitive stance. The company&#8217;s focus on enhancing operational efficiencies and expanding its product offerings through acquisitions like BKI positions it well for future growth and profitability.
Investors can gain exposure to the stock via&nbsp;the Listed Funds Trust Horizon Kinetics Blockchain Development ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCDF#NYSE">BCDF</a>) and the Tema ETF Trust Tema Monopolies and Oligopolies ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/TOLL#BATS">TOLL</a>).
Price Action: ICE shares are up 0.46% at $158.85 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40693687/cme-group-downgraded-analyst-sees-cutthroat-competition-from-bgc-group-cboe-global-" target="_blank" rel="noreferrer noopener">CME Group Downgraded: Analyst Sees Cutthroat Competition From BGC Group, Cboe Global &amp; Intercontinental Exchange</a></li>
</ul>

Equities

Initiation

Listed Funds Trust Horizon Kinetics Blockchain Development ETF

BCDF

TOLL

ICE's Resilient Business Model and Technological Advancements Drive an Outperform Rating - Here's Why

Senior Israeli Official Says Israel Was Aiming To Take Out About Half Of Hezbollah's Missile And Rocket Capabilities 'And We Did'

Providing a diverse range of perspectives from bullish to bearish, 18 analysts have published ratings on Robinhood Markets (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) in the last three months.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">9</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $22.22, a high estimate of $32.00, and a low estimate of $17.00. This current average reflects an increase of 6.72% from the previous average price target of $20.82. 
<img src="https://www.benzinga.com/files/images/story/2024/1727463704_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The analysis of recent analyst actions sheds light on the perception of Robinhood Markets by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$23.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$27.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$20.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Brian Bedell</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Buy</td>
<td>$24.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Michael Cyprys</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$21.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Craig Siegenthaler</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$32.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$18.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$23.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Maintains</td>
<td>Market Outperform</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Kenneth Worthington</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$17.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Kyle Voigt</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$22.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Christopher Allen</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Neutral</td>
<td>$18.00</td>
<td>-</td>
</tr>
<tr>
<td>Alex Markgraff</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Benjamin Budish</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$20.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Patrick Moley</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$18.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Robinhood Markets. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Robinhood Markets compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Robinhood Markets's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Robinhood Markets's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/HOOD/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Robinhood Markets analyst ratings.</a>
<h2>Get to Know Robinhood Markets Better</h2>
Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fractional shares, recurring investments, and IPO Access. It earns transaction-based revenues from routing user orders for options, equities, and cryptocurrencies to market makers when a routed order is executed.
<h3>Robinhood Markets's Financial Performance</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Robinhood Markets's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 40.33%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: Robinhood Markets's net margin excels beyond industry benchmarks, reaching 27.57%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Robinhood Markets's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.68%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Robinhood Markets's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.43%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Robinhood Markets's debt-to-equity ratio is below the industry average. With a ratio of 0.71, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HOOD

The Analyst Verdict: Robinhood Markets In The Eyes Of 18 Experts

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Meta Platforms&rsquo; (NASDAQ:<a href="https://investorplace.com/stock-quotes/meta-stock-quote/">META</a>) stock surge continues to be driven by its fundamentals, with robust growth in ad revenue continuing to remain the story with most investors. With over 3 billion daily app users, engagement has soared alongside the company&rsquo;s stock price.



This surge in engagement has allowed META stock to exceed expectations, reporting earnings per share of $4.27 this past quarter, up 61.7% from the same quarter last year. The company&rsquo;s fiscal year estimates also show strong growth. Last quarter, revenue soared to $40.11 billion, a 24.7% year-over-year increase. Meta has consistently surpassed EPS and revenue estimates, and I&rsquo;d expect this trend to continue long-term.



The company&rsquo;s earnings expanded notably. Despite Reality Labs&rsquo; widening losses, overall earnings nearly doubled in 2023, with operating income surging to $47 billion. Operating profit margin reached 35%. The company aims to regain pre-pandemic profitability levels. Analysts predict a 33% EPS rise to $20. Margins may approach 50%, enhancing Meta&rsquo;s premium valuation.



That said, there are some key headwinds to factor into the equation. Here&rsquo;s the latest one investors may not be aware of. Let&rsquo;s dive into whether Meta is still worth buying on this news.



<h2>Illegal Drug Sales Investigation</h2>



Federal prosecutors, per unnamed sources in the Wall Street Journal, are <a href="https://www.theverge.com/2024/3/16/24103027/us-investigation-meta-drug-sales-profits">investigating Meta Platform&rsquo;s potential role in drug sales</a> via its platforms. Subpoenas requested records on drug-related content. Meta spokesperson emphasized policy enforcement against illicit drug sales and cooperation with law enforcement. The response from rivals such as TikTok&rsquo;s remains undisclosed.



In 2022, researchers gathered Facebook prescription drug ad data for the Journal and received a subpoena. Meta didn&rsquo;t respond immediately. Meta&rsquo;s Nick Clegg announced joining the Alliance to Prevent Drug Harms. The U.S. and UN collaborate with Meta and others to combat online drug activity.



For now, this appears to simply be a probe, but it&rsquo;s something investors may want to keep an eye on. Meta has been the focus of regulator scrutiny in the past, and that&rsquo;s mainly the negative catalyst that took this stock to 2022 lows. A repeat of such a situation would not be good for existing shareholders, but the outcome of this probe remains unknown. So, for now, the market appears to be brushing off the news.



<h2>There Are Other Catalysts to Consider</h2>



Aside from Meta&rsquo;s regulatory struggles, there are plenty of positive catalysts to consider. From the company&rsquo;s AI integrations to its strong and growing social media empire, this is a stock that&rsquo;s garnered attention for its core platform and user base. That won&rsquo;t change anytime soon.



Additionally, an integration with Verb Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/verb-stock-quote/">VERB</a>), creator of MARKET.live, with Meta Platforms for <a href="https://www.investing.com/news/stock-market-news/verb-technology-partners-with-meta-for-integrated-shopping-93CH-3339962">seamless in-app shopping on Facebook and Instagram</a> is driving interest in META stock from some investors. This collaboration broadens MARKET.live&rsquo;s reach, and should allow Meta to benefit from in-app shopping on its social platforms. 



This deal should align well for both companies, as Meta seeks to broaden reach and value for stakeholders, per a press release. This reflects ongoing innovation in social shopping. Further updates will be shared via social media and MARKET.live.



<h2>META Stock Could Continue to Soar</h2>



These past two years have been much better than the 2022 investors were forced to endure with META stock. Of course, Zuckerberg has shifted his focus from the metaverse to his core business, instead focusing on efficiency and high-growth opportunities. Investors have liked what they see, and this has clearly been reflected in the company&rsquo;s fundamentals.



Over the long-term, I don&rsquo;t think this picture will change. The company&rsquo;s reported net income in 2023 was $39.1 billion, equating to $14.87 per share. With a price-earnings ratio of 33.4-times, Meta appears to be fairly-valued relative to the Nasdaq-100 index. However, analysts anticipate a 22.4% earnings growth in 2024, suggesting potential undervaluation by year-end. 



Despite a 547% gain since October 2022, Meta stock remains a promising investment, at least in my books.



On the date of publication, Chris MacDonald did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/">Publishing Guidelines</a>.
<div>Chris MacDonald&rsquo;s love for investing led him to pursue an MBA in Finance and take on a number of management roles in corporate finance and venture capital over the past 15 years. His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/forget-the-drug-probe-metas-fundamentals-make-it-a-must-buy-stock/">Forget the Drug Probe: Meta&#8217;s Fundamentals Make It a Must-Buy Stock</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Forget the Drug Probe: Meta's Fundamentals Make It a Must-Buy Stock

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are worth checking out as we dive into all of the biggest movements on Wednesday morning!



Moving stocks are earnings reports, acquisition plans, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Etao International (NASDAQ:<a href="https://investorplace.com/stock-quotes/etao-stock-quote/">ETAO</a>) stock is rocketing more than 213% after <a href="https://www.prnewswire.com/news-releases/etao-announces-a-reverse-stock-split-effect-on-march-25-2024-302093539.html">announcing a reverse stock split</a>.</li>



<li>Oblong (NASDAQ:<a href="https://investorplace.com/stock-quotes/oblg-stock-quote/">OBLG</a>) shares are soaring close to 63% following the <a href="https://www.nasdaq.com/press-release/oblong-announces-financial-results-for-fourth-quarter-2023-and-provides-business">release of its Q4 earnings report</a>.</li>



<li>Nature&rsquo;s Miracle (NASDAQ:<a href="https://investorplace.com/stock-quotes/nmhi-stock-quote/">NMHI</a>) stock is surging over 35% on <a href="https://www.nasdaq.com/press-release/natures-miracle-inc.-announces-memorandum-of-understanding-to-acquire-future-tech-inc">plans to acquire Future Tech</a>.</li>



<li>Mangoceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/mgrx-stock-quote/">MGRX</a>) shares are gaining more than 34% alongside heavy pre-market trading.</li>



<li>Taysha Gene Therapies (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsha-stock-quote/">TSHA</a>) stock is increasing over 28% after <a href="https://www.globenewswire.com/news-release/2024/03/19/2848955/0/en/Taysha-Gene-Therapies-Reports-Full-Year-2023-Financial-Results-and-Provides-Corporate-and-Clinical-Updates.html">releasing its latest earnings report</a>.</li>



<li>EzFill (NASDAQ:<a href="https://investorplace.com/stock-quotes/ezfl-stock-quote/">EZFL</a>) shares are rising more than 17% on Wednesday morning.</li>



<li>Vision Marine (NASDAQ:<a href="https://investorplace.com/stock-quotes/vmar-stock-quote/">VMAR</a>) stock is climbing over 16% this morning.</li>



<li>FibroBiologics (NASDAQ:<a href="https://investorplace.com/stock-quotes/fblg-stock-quote/">FBLG</a>) shares are heading more than 15% higher as they continue to rally on <a href="https://www.nasdaq.com/press-release/fibrobiologics-announces-preliminary-proof-of-concept-for-fibroblast-based-diabetes">diabetic treatment news</a>.</li>



<li>Jiuzi (NASDAQ:<a href="https://investorplace.com/stock-quotes/jzxn-stock-quote/">JZXN</a>) stock is jumping over 14% without any clear news today.</li>



<li>Canopy Growth (NASDAQ:<a href="https://investorplace.com/stock-quotes/cgc-stock-quote/">CGC</a>) shares are up more than 14% as a <a href="https://seekingalpha.com/news/4080710-cannabis-stocks-rally-for-second-session-in-a-row-led-by-canopy-growth">cannabis rally continues</a>.</li>
</ol><h2>Top 10 Losers</h2>



<ol><li>Momentus (NASDAQ:<a href="https://investorplace.com/stock-quotes/mnts-stock-quote/">MNTS</a>) stock is diving over 18% after seeing a similar rally yesterday.</li>



<li>Ontrak (NASDAQ:<a href="https://investorplace.com/stock-quotes/otrk-stock-quote/">OTRK</a>) shares are retreating more than 17% <a href="https://investorplace.com/2024/03/why-is-ontrak-otrk-stock-up-105-today/">after a rally on Tuesday</a>.</li>



<li>Verb Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/verb-stock-quote/">VERB</a>) stock is tumbling over 14% <a href="https://investorplace.com/2024/03/why-is-verb-technology-verb-stock-up-again-today/">after recent rallies</a>.</li>



<li>Harrow (NASDAQ:<a href="https://investorplace.com/stock-quotes/hrow-stock-quote/">HROW</a>) shares are taking a more than 13% beating with the release of its <a href="https://www.nasdaq.com/press-release/harrow-announces-fourth-quarter-and-year-end-2023-financial-results-2024-03-19">Q4 earnings report</a>.</li>



<li>Aquestive Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/aqst-stock-quote/">AQST</a>) stock is sliding over 12% on a <a href="https://www.globenewswire.com/news-release/2024/03/19/2848956/0/en/Aquestive-Therapeutics-Announces-Proposed-Public-Offering-of-Common-Stock.html">proposed public offering</a>.</li>



<li>Brand Engagement Network (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnai-stock-quote/">BNAI</a>) shares are decreasing more than 11% alongside recent volatility.</li>



<li>Kazia Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kzia-stock-quote/">KZIA</a>) stock is dropping over 11% this morning.</li>



<li>Joann (NASDAQ:<a href="https://investorplace.com/stock-quotes/joan-stock-quote/">JOAN</a>) shares are falling more than 11% <a href="https://investorplace.com/2024/03/why-is-joann-joan-stock-up-15-today/">as bankruptcy proceedings</a> continue to weigh on the stock.</li>



<li>Global Mofy Metaverse (NASDAQ:<a href="https://investorplace.com/stock-quotes/gmm-stock-quote/">GMM</a>) stock is slipping over 9% on Wednesday morning.</li>



<li>Euronav (NYSE:<a href="https://investorplace.com/stock-quotes/eurn-stock-quote/">EURN</a>) shares close out our pre-market stock movers down more than 9% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318170216&amp;type=PDF&amp;symbol=EURN&amp;cdn=ec8465a34a1b599377c9e5827b7351b0&amp;companyName=Euronav+NV&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-03-19">following a takeover update</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/03/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-march-20th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

Verb Technology Company Inc (VERB) stock has fallen -94.46% over the last 12 months. InvestorsObserver's proprietary ranking system, gives VERB stock a score of  18 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 1. VERB's rank also includes a long-term technical score of 53.  VERB

Should You Accumulate Verb Technology Company Inc (VERB) Stock Thursday?

Warning: VERB is at high risk of performing badly

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We&rsquo;re starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning!



Moving stocks this morning are acquisition deals, collaborations, earnings reports and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Rallybio (NASDAQ:<a href="https://investorplace.com/stock-quotes/rlyb-stock-quote/">RLYB</a>) stock is rocketing more than 76% alongside <a href="https://www.nasdaq.com/press-release/rallybio-announces-collaboration-to-advance-therapeutic-solutions-for-pregnant">news of a collaboration</a> with Johnson &amp; Johnson (NYSE:<a href="https://investorplace.com/stock-quotes/jnj-stock-quote/">JNJ</a>).</li>



<li>Rent the Runway (NASDAQ:<a href="https://investorplace.com/stock-quotes/rent-stock-quote/">RENT</a>) shares are soaring over 42% after releasing its <a href="https://finance.yahoo.com/news/rent-runway-inc-announces-fourth-200100025.html">Q4 earnings report</a>.</li>



<li>Alpine Immune Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/alpn-stock-quote/">ALPN</a>) stock is surging more than 36% after <a href="https://www.businesswire.com/news/home/20240410918915/en/Vertex-Enters-Into-Agreement-to-Acquire-Alpine-Immune-Sciences">announcing an acquisition deal</a>.</li>



<li>Zooz Power (NASDAQ:<a href="https://investorplace.com/stock-quotes/zooz-stock-quote/">ZOOZ</a>) shares are gaining over 23% with heavy pre-market trading.</li>



<li>Verb Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/verb-stock-quote/">VERB</a>) stock is increasing more than 18% on strong early morning trading.</li>



<li>VIA Optronics (NYSE:<a href="https://investorplace.com/stock-quotes/viao-stock-quote/">VIAO</a>) shares are rising over 12% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318227238&amp;type=PDF&amp;symbol=VIAO&amp;cdn=2109fb9c2a0d0f70b25e0b85b53c03bf&amp;companyName=VIA+optronics+AG+American+Depositary+Shares+each+representing+one-fifth+of+an&amp;formType=6-K&amp;formDescription=Report+of+foreign+private+issuer+pursuant+to+Rule+13a-16+or+15d-16+under+the+Securities+Exchange+Act+of+1934&amp;dateFiled=2024-04-10">new cockpit launch yesterday</a>.</li>



<li>Energy Focus (NASDAQ:<a href="https://investorplace.com/stock-quotes/efoi-stock-quote/">EFOI</a>) stock is climbing more than 11% without any clear news this morning.</li>



<li>Vera Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/vera-stock-quote/">VERA</a>) shares are jumping over 11% as it <a href="https://www.businesswire.com/news/home/20240410918915/en/Vertex-Enters-Into-Agreement-to-Acquire-Alpine-Immune-Sciences">plans to acquire</a> Alpine Immune Sciences.</li>



<li>N2OFF (NASDAQ:<a href="https://investorplace.com/stock-quotes/nito-stock-quote/">NITO</a>) stock is getting a more than 10% boost despite a lack of news this morning.</li>



<li>CuriosityStream (NASDAQ:<a href="https://investorplace.com/stock-quotes/curi-stock-quote/">CURI</a>) shares are up over 10% this morning.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) stock is crashing more than 46% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318229263&amp;type=PDF&amp;symbol=APVO&amp;cdn=3bc6f4485208619435d54288b4004e93&amp;companyName=Aptevo+Therapeutics+Inc.&amp;formType=EFFECT&amp;formDescription=Notice+of+Effectiveness&amp;dateFiled=2024-04-10">effecting a share offering</a>.</li>



<li>ClearOne (NASDAQ:<a href="https://investorplace.com/stock-quotes/clro-stock-quote/">CLRO</a>) shares are plummeting over 44% without any apparent news today.</li>



<li>EpicQuest Education (NASDAQ:<a href="https://investorplace.com/stock-quotes/eeiq-stock-quote/">EEIQ</a>) stock is diving more than 23% on Thursday morning.</li>



<li>Acorda Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/acor-stock-quote/">ACOR</a>) shares are taking an over 18% beating today.</li>



<li>Edible Garden AG (NASDAQ:<a href="https://investorplace.com/stock-quotes/edbl-stock-quote/">EDBL</a>) stock is tumbling more than 16% without any obvious news this morning.</li>



<li>Hub Cyber Security (NASDAQ:<a href="https://investorplace.com/stock-quotes/hubc-stock-quote/">HUBC</a>) shares are sliding over 13% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318229307&amp;type=PDF&amp;symbol=HUBC&amp;cdn=83924678d306ab47b924e472e477b95a&amp;companyName=Hub+Cyber+Security+Ltd.&amp;formType=SC+13D%2FA&amp;formDescription=%5BAmend%5D+General+statement+of+acquisition+of+beneficial+ownership&amp;dateFiled=2024-04-11">on an investor update</a>.</li>



<li>Cadrenal Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cvkd-stock-quote/">CVKD</a>) stock is dropping more than 13% <a href="https://www.nasdaq.com/press-release/cadrenal-therapeutics-receives-fda-orphan-drug-designation-for-tecarfarin-for">following a rally yesterday</a>.</li>



<li>Adial Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/adil-stock-quote/">ADIL</a>) shares are retreating over 13% after a <a href="https://investorplace.com/2024/04/why-is-adial-pharmaceuticals-adil-stock-up-59-today/">major rally on Wednesday</a>.</li>



<li>Nyxoah (NASDAQ:<a href="https://investorplace.com/stock-quotes/nyxh-stock-quote/">NYXH</a>) stock is declining 13% today.</li>



<li>Meiwu Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/wnw-stock-quote/">WNW</a>) shares close out our pre-market stock movers down more than 12% after rallying yesterday.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-11th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Verb Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/verb-stock-quote/">VERB</a>) just reported results for the first quarter of 2024.<ul><li>Verb Tech reported earnings per share of -11 cents. This was above the analyst estimate for EPS of -12 cents.</li><li>The company reported revenue of $7,000.</li><li>This was 93% worse than the analyst estimate for revenue of $100,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/verb-stock-earnings-verb-tech-for-q1-of-2024/">VERB Stock Earnings: Verb Tech Beats EPS, Misses Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VERB Stock Earnings: Verb Tech Beats EPS, Misses Revenue for Q1 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to dive into the biggest pre-market stock movers for Thursday as we check out all of the hottest news this morning!



Moving stocks this morning are earnings reports, new contracts, a CEO change and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Cue Health (NASDAQ:<a href="https://investorplace.com/stock-quotes/hlth-stock-quote/">HLTH</a>) stock is rocketing more than 49% despite <a href="https://investorplace.com/2024/05/why-is-cue-health-hlth-stock-down-40-today/">plans to close its business</a>.</li>



<li>Smart for Life (NASDAQ:<a href="https://investorplace.com/stock-quotes/smfl-stock-quote/">SMFL</a>) shares are soaring over 48% after <a href="https://www.nasdaq.com/press-release/smart-for-life-announces-updates-on-successful-completion-of-restructuring-program">completing a restructuring program</a>.</li>



<li>Molecular Templates (NASDAQ:<a href="https://investorplace.com/stock-quotes/mtem-stock-quote/">MTEM</a>) stock is surging more than 30% without any clear news this morning.</li>



<li>OneMedNet (NASDAQ:<a href="https://investorplace.com/stock-quotes/onmd-stock-quote/">ONMD</a>) shares are increasing over 29% after <a href="https://finance.yahoo.com/news/onemednet-inks-agreement-global-top-200500512.html">signing a new contract</a>.</li>



<li>Kintara Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ktra-stock-quote/">KTRA</a>) stock is rising more than 26% alongside heavy pre-market trading.</li>



<li>Cheche (NASDAQ:<a href="https://investorplace.com/stock-quotes/ccg-stock-quote/">CCG</a>) shares are gaining over 21% with its <a href="https://www-thailand--business--news-com.webpkgcache.com/doc/-/s/www.thailand-business-news.com/thailand-prnews/cheche-group-reports-first-quarter-2024-unaudited-financial-results">latest earnings release</a>.</li>



<li>Verb Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/verb-stock-quote/">VERB</a>) stock is climbing more than 17% with strong early morning trading.</li>



<li>Nexalin Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/nxl-stock-quote/">NXL</a>) shares are jumping over 15% despite a lack of news.</li>



<li>Burlington Stores (NYSE:<a href="https://investorplace.com/stock-quotes/burl-stock-quote/">BURL</a>) stock is getting a more than 14% boost with its <a href="https://finance.yahoo.com/news/burlington-stores-inc-reports-first-104500806.html">Q1 earnings report</a>.</li>



<li>C3.ai (NYSE:<a href="https://investorplace.com/stock-quotes/ai-stock-quote/">AI</a>) shares are up over 14% after <a href="https://www.investors.com/news/technology/c3-ai-stock-ai-stock-c3-ai-earnings-news-q12024/">beating Q1 estimates</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>NovaBay Pharmaceuticals (NYSEMKT:<a href="https://investorplace.com/stock-quotes/nby-stock-quote/">NBY</a>) stock is plummeting more than 40% alongside <a href="https://www.nasdaq.com/press-release/novabay-pharmaceuticals-announces-approval-all-proposals-its-2024-annual-meeting">annual shareholder meeting plans</a>.</li>



<li>UiPath (NYSE:<a href="https://investorplace.com/stock-quotes/path-stock-quote/">PATH</a>) shares are diving over 30% on <a href="https://www.nasdaq.com/press-release/uipath-re-appoint-daniel-dines-chief-executive-officer-rob-enslin-steps-down-ceo-and">a CEO change</a>.</li>



<li>Innovative Eyewear (NASDAQ:<a href="https://investorplace.com/stock-quotes/lucy-stock-quote/">LUCY</a>) stock is retreating more than 21% on a <a href="https://finance.yahoo.com/news/innovative-eyewear-inc-announces-2-184300125.html">new direct offering</a>.</li>



<li>Sonoma Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/snoa-stock-quote/">SNOA</a>) shares are tumbling over 18% without any obvious news today.</li>



<li>SCWorx (NASDAQ:<a href="https://investorplace.com/stock-quotes/worx-stock-quote/">WORX</a>) stock is taking a more than 16% beating this morning.</li>



<li>Salesforce (NYSE:<a href="https://investorplace.com/stock-quotes/crm-stock-quote/">CRM</a>) shares are dropping over 16% on <a href="https://finance.yahoo.com/video/salesforce-stock-sinking-q2-earnings-202330512.html">poor Q2 guidance</a>.</li>



<li>Onconetix (NASDAQ:<a href="https://investorplace.com/stock-quotes/onco-stock-quote/">ONCO</a>) stock is decreasing close to 16% after an unexpected rally yesterday.</li>



<li>Sharps Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/stss-stock-quote/">STSS</a>) shares are falling more than 14% <a href="https://investorplace.com/2024/05/why-is-sharps-technology-stss-stock-up-194-today/">following a recent rally</a>.</li>



<li>Fangdd Network (NASDAQ:<a href="https://investorplace.com/stock-quotes/duo-stock-quote/">DUO</a>) stock is slipping over 13% today.</li>



<li>Agilent Technologies (NYSE:<a href="https://investorplace.com/stock-quotes/a-stock-quote/">A</a>) shares close out our pre-market stock movers down over 13% on <a href="https://finance.yahoo.com/news/agilent-reports-q2-earnings-key-220003997.html">fiscal Q2 earnings</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-may-30th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Verb Tech (NASDAQ:<a href="https://investorplace.com/stock-quotes/verb-stock-quote/">VERB</a>) just reported results for the second quarter of 2024.<ul><li>Verb Tech reported earnings per share of -2 cents. This was above the analyst estimate for EPS of -3 cents.</li><li>The company reported revenue of $37,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/verb-stock-earnings-verb-tech-for-q2-of-2024/">VERB Stock Earnings: Verb Tech Beats EPS for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VERB Stock Earnings: Verb Tech Beats EPS for Q2 2024

ACOR

ADIL

ALPN

APVO

AQST

BNAI

BURL

CLRO

CURI

CVKD

EDBL

EEIQ

EFOI

ETAO

EURN

EZFL

FBLG

HLTH

HROW

JOAN

JZXN

KTRA

KZIA

LUCY

MGRX

MNTS

MTEM

NITO

NMHI

NYXH

OBLG

ONCO

ONMD

OTRK

PATH

RENT

RLYB

SMFL

SNOA

STSS

TSHA

VERA

VERB

VIAO

VMAR

WORX

ZOOZ

Press Releases

VERB's MARKET.live Livestream Shopping Business Plan is Now Fully Funded

VERB's MARKET.live x TikTok Shop Partnership Event Set for April 25th

VERB's MARKET.live Adds Another 100 Retail Brands to Its Livestream Social Shopping Platform

VERB's MARKET.live x TikTok Shop Partnership Event Draws Over 300 Attendees

VERB's Healthy Balance and Enhanced Shareholder Equity Behind Nasdaq's Grant of 6-Month Extension to Regain Compliance With Bid Price Rule

VERB's MARKET.live Unveils Major TikTok Shop Technology Expansion

VERB's MARKET.live Selected to Deliver Exclusive Shoppable Livestream Simulcast of the Dane Cook & David Meltzer Event "The Collab" Live From Youtube Theatre

VERB's MARKET.live Partners with BeautyStat and TikTok to Bring Exclusive Skincare Event to TikTok Audience

VERB's MARKET.live Launches Groundbreaking Pinterest Technology Integration

VERB Announces First of 2 New Business Verticals 'GO FUND YOURSELF'  - First Interactive Social Crowd Funding Platform

Comments

Verb Tech

Interés en corto

Verb Tech (NASDAQ:VERB) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL